A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers
Clinical trial NCT00813241 · COMPLETED
Trial details
- NCT number
- NCT00813241
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.